Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and pharmaceutical compositions for the treatment of myelodysplastic syndromes

Methods and pharmaceutical compositions for the treatment of myelodysplastic syndromes

US Patent 9675590 · Granted Jun 13, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Masitinib for the treatment of sickle cell disease2025
Methods and pharmaceutical compositions for the treatment of diseases mediated b2023
Methods and pharmaceutical compositions for the treatment of mast cell diseases2022
TET2 as a diagnostic and pronostic marker in hematopoietic neoplasms2021
Methods and pharmaceutical compositions for the treatment of systemic mastocytos2021
Methods and pharmaceutical compositions for the treatment of systemic mastocytos2021
TET2 as a diagnostic and prognostic marker in hematopoietic neoplasms2020
Polypeptides capable of inhibiting the binding between leptin and Neuropilin-12020
Use of hydroxycarbamide for preventing retinal nonperfusion2020
Methods for determining the risk of acute graft versus host disease2018
Composition comprising a combination of DNA methylation inhibitor and a vitamin 2018
Methods and pharmaceutical compositions for the treatment of beta-thalassemias2018